Atossa Therapeutics (NASDAQ: ATOS) deepens Z-endoxifen bet as 2025 losses widen and rare disease optionality grows
Read More 10 minute read General business news Savills (LSE: SVS) doubles down on investment banking with $1.1bn Eastdil Secured deal as FY25 earnings beat expectations Savills (SVS) posts FY25 revenue of £2.55bn and agrees to acquire Eastdil Secured for $1.1bn, targeting number one position in US real estate investment banking. Read more. byVenkateshMarch 12, 2026